N-[5-[4-[(6-Cyano-3-pyridinyl)methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl] cyclopropanecarboxamide
99%
- Product Code: 67628
Alias:
N-[5-[4-[(6-cyano-3-pyridyl)methoxy]phenyl][1,2,4]triazolo[1,5-A]pyridin-2-yl] -Cyclopropanecarboxamide; N-(5-(4-((6-cyanopyridin-3-yl)methoxy)phenyl)-[1,2,4]thiazolo[1,5-A] Pyridin-2-yl)cyclopropanecarboxamide
CAS:
1206101-20-3
| Molecular Weight: | 410.43 g./mol | Molecular Formula: | C₂₃H₁₈N₆O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
This compound is primarily utilized in the field of pharmaceutical research and development, particularly in the study of kinase inhibitors. It has shown potential in targeting specific enzymes involved in various cellular processes, making it a candidate for the treatment of diseases such as cancer and inflammatory disorders. Its structure allows it to interact effectively with kinase domains, potentially inhibiting abnormal cell proliferation and signaling pathways. Researchers are exploring its efficacy in preclinical models to assess its therapeutic potential and optimize its pharmacokinetic properties for future clinical applications.
Product Specification:
| Test | Specification |
|---|---|
| Purity | 98.5 100% |
| Appearance | POWDER |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿10,520.00 |
+
-
|
| 0.025 | 10-20 days | ฿34,000.00 |
+
-
|
| 0.100 | 10-20 days | ฿86,600.00 |
+
-
|
N-[5-[4-[(6-Cyano-3-pyridinyl)methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl] cyclopropanecarboxamide
This compound is primarily utilized in the field of pharmaceutical research and development, particularly in the study of kinase inhibitors. It has shown potential in targeting specific enzymes involved in various cellular processes, making it a candidate for the treatment of diseases such as cancer and inflammatory disorders. Its structure allows it to interact effectively with kinase domains, potentially inhibiting abnormal cell proliferation and signaling pathways. Researchers are exploring its efficacy in preclinical models to assess its therapeutic potential and optimize its pharmacokinetic properties for future clinical applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :